-
公开(公告)号:US20230416273A1
公开(公告)日:2023-12-28
申请号:US18272884
申请日:2022-01-21
Applicant: BASF SE
Inventor: Christopher Koradin , Martin John McLaughlin , Harish Shinde , Rahul Kaduskar , Ronald Goetz , Guillaaume Michel Jaques Garivet
IPC: C07D513/04
CPC classification number: C07D513/04
Abstract: The present invention relates to a method for preparing an enantiomerically enriched form of 3-(2-chlorothiazol-5-yl)-8-methyl-7-oxo-6-phenyl-2,3-dihydrothiazolo[3,2-a]pyrimidin-4-ium-5-olate.